泰格医药
(300347)
| 流通市值：286.72亿 | | | 总市值：433.07亿 |
| 流通股本：5.78亿 | | | 总股本：8.72亿 |
| 报告期 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 7,419,991,842.25 | 7,417,101,360.17 | 8,137,910,878.32 | 7,616,130,648.84 |
| 应收票据及应收账款 | 1,260,914,900.86 | 1,198,166,368.91 | 1,210,150,914.48 | 1,082,536,393.77 |
| 其中：应收票据 | 214,560 | 22,157,269.56 | 8,357,204.1 | 5,161,220 |
| 应收账款 | 1,260,700,340.86 | 1,176,009,099.35 | 1,201,793,710.38 | 1,077,375,173.77 |
| 预付款项 | 56,545,630.65 | 69,481,207.57 | 74,560,205.44 | 67,850,285.39 |
| 其他应收款合计 | 79,577,742.45 | 86,828,836.24 | 76,763,196.64 | 75,589,957.18 |
| 其中:应收利息 | 19,636,120.18 | 14,161,652.69 | 14,807,833.41 | 12,897,852 |
| 存货 | 23,397,667.4 | 27,238,796.09 | 26,534,685.47 | 23,126,561.45 |
| 合同资产 | 2,364,435,242.53 | 2,607,043,936.11 | 2,364,141,878.36 | 2,272,502,782.23 |
| 其他流动资产 | 97,139,803.4 | 34,544,474.64 | 66,356,677.39 | 41,583,601.82 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 11,344,141,125.21 | 11,465,404,979.73 | 11,976,418,436.1 | 11,215,264,660.87 |
| 非流动资产: | | | | |
| 债权投资 | - | 38,565,292.6 | 39,086,642.14 | 21,155,123.31 |
| 长期股权投资 | 2,977,027,510.07 | 2,898,551,203.83 | 2,413,561,051.87 | 2,300,350,283.87 |
| 其他权益工具投资 | 14,507,959.32 | 6,447,737.16 | 3,844,186.64 | 3,704,270.84 |
| 其他非流动金融资产 | 10,231,701,776.67 | 10,726,054,031.72 | 10,609,474,095.03 | 10,085,929,577.13 |
| 固定资产 | 638,751,357.57 | 648,667,308.4 | 577,533,507.15 | 555,018,224.75 |
| 在建工程 | 324,278,367.3 | 249,876,779.43 | 257,333,749.68 | 221,813,205.71 |
| 使用权资产 | 509,578,081.32 | 533,748,812.65 | 536,428,229.34 | 549,152,585.68 |
| 无形资产 | 371,129,876.93 | 313,052,883.68 | 332,425,202.75 | 335,650,603.45 |
| 商誉 | 2,764,188,189.08 | 2,833,170,843.15 | 2,549,178,403.84 | 2,495,838,547.82 |
| 长期待摊费用 | 213,751,116.95 | 192,913,024.9 | 200,509,243.9 | 203,856,709.49 |
| 递延所得税资产 | 134,791,338.83 | 148,653,554.28 | 141,532,406.61 | 134,462,892.05 |
| 其他非流动资产 | 156,895,649.92 | 17,342,961.33 | 29,350,577.01 | 49,931,015.02 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 18,336,601,223.96 | 18,607,044,433.13 | 17,690,257,295.96 | 16,956,863,039.12 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 29,680,742,349.17 | 30,072,449,412.86 | 29,666,675,732.06 | 28,172,127,699.99 |
| 流动负债: | | | | |
| 短期借款 | 1,969,693,500 | 2,533,838,000 | 2,363,113,400 | 2,082,585,650 |
| 应付票据及应付账款 | 249,307,924.54 | 168,543,507.22 | 174,396,952.39 | 175,982,484.29 |
| 应付账款 | 249,307,924.54 | 168,543,507.22 | 174,396,952.39 | 175,982,484.29 |
| 合同负债 | 680,489,184.98 | 794,268,613.92 | 876,381,210.99 | 870,900,929.39 |
| 应付职工薪酬 | 357,979,354.68 | 228,360,655.15 | 181,907,354.06 | 170,191,493.18 |
| 应交税费 | 220,759,136.97 | 198,212,936.34 | 205,765,997.38 | 180,537,915.05 |
| 其他应付款合计 | 78,673,426.67 | 105,095,415.55 | 578,805,375.96 | 52,864,061.13 |
| 其中:应付利息 | 6,392,172.03 | 3,265,437.85 | 4,987,757.12 | 4,100,993.67 |
| 应付股利 | 3,470,035.91 | 3,145,595.72 | 477,591,539.14 | 1,641,039.4 |
| 一年内到期的非流动负债 | 563,595,304.44 | 196,245,720.79 | 208,559,607.83 | 211,843,127.17 |
| 其他流动负债 | 18,238,459.3 | 47,523,196.86 | 44,320,634.48 | 52,089,285.55 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 4,138,736,291.58 | 4,272,088,045.83 | 4,633,250,533.09 | 3,796,994,945.76 |
| 非流动负债: | | | | |
| 长期借款 | 434,223,304.63 | 514,545,308.97 | 288,571,372.87 | 280,710,389.8 |
| 租赁负债 | 423,108,703.51 | 440,137,779.9 | 453,102,923.06 | 466,590,632.04 |
| 长期应付款 | - | - | 43,296,885.65 | 40,722,864 |
| 长期应付职工薪酬 | 2,538,825.71 | 49,283,079.71 | 44,100,866.77 | 36,705,420.33 |
| 递延收益 | 14,594,433.99 | 14,906,502.53 | 15,114,710.65 | 14,481,196.01 |
| 递延所得税负债 | 213,978,644.49 | 230,255,171.62 | 231,388,849.78 | 217,377,396.33 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,088,443,912.33 | 1,249,127,842.73 | 1,075,575,608.78 | 1,056,587,898.51 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 5,227,180,203.91 | 5,521,215,888.56 | 5,708,826,141.87 | 4,853,582,844.27 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 872,418,220 | 872,418,220 | 872,418,220 | 872,418,220 |
| 资本公积 | 11,708,834,896.63 | 11,883,728,680.02 | 11,872,789,741.96 | 11,876,590,382.57 |
| 减:库存股 | 869,336,804.33 | 869,336,804.33 | 869,336,804.33 | 869,336,804.33 |
| 其他综合收益 | 103,534,270.25 | 106,989,317.23 | 135,421,619.35 | 34,690,635.45 |
| 盈余公积 | 436,529,393.76 | 391,861,320.51 | 391,861,320.51 | 391,861,320.51 |
| 未分配利润 | 8,774,794,749.44 | 8,674,217,263.74 | 8,182,949,839.78 | 7,838,789,639.95 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 21,026,774,725.75 | 21,059,877,997.17 | 20,586,103,937.27 | 20,145,013,394.15 |
| 少数股东权益 | 3,426,787,419.51 | 3,491,355,527.13 | 3,371,745,652.92 | 3,173,531,461.57 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 24,453,562,145.26 | 24,551,233,524.3 | 23,957,849,590.19 | 23,318,544,855.72 |
| 负债和股东权益合计 | 29,680,742,349.17 | 30,072,449,412.86 | 29,666,675,732.06 | 28,172,127,699.99 |
| 公告日期 | 2024-03-29 | 2023-10-28 | 2023-08-26 | 2023-04-26 |
| 审计意见(境内) | 标准无保留意见 | | | |